SEC Filings TLDR
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2025-10-28BSAC6-KBanco Santander-Chile Issues Bonds in Local Marketdebt financingMEDIUM
Banco Santander-Chile has issued dematerialized and bearer bonds in the local market as of October 28, 2025. The bonds, part of the Series AA-22 BSTD220425, amount to UF 1,000,000 and are set to mature on April 1, 2040. The average placement rate for these securities was 3.02%. This issuance is in compliance with the r...
2025-10-28ARMN6-KPreliminary Economic Assessment for the Toroparu Projectoperation relatedHIGH
Aris Mining Corporation has released a Preliminary Economic Assessment (PEA) for the Toroparu Project in Guyana, outlining a long-life open-pit gold mine with robust economics and low operating costs. The project, located in the Cuyuni-Mazaruni Region, includes the Toroparu and Sona Hill deposits, which have been defin...
2025-10-28AMBP6-KArdagh Metal Packaging S.A. Updates on Recapitalization Transactionfinancial obligation triggerMEDIUM
Ardagh Metal Packaging S.A. (the "Company") reported updates related to the consent solicitations in connection with Ardagh Group S.A.'s recapitalization transaction. The updates include the receipt of required majority consents for the SSN 50% Condition, SUN 50% Condition, and PIK Notes 50% Condition, as announced on ...
2025-10-28ATS6-KATS Corporation Second Quarter Earnings Call AnnouncementearningsMEDIUM
ATS Corporation (TSX: ATS) (NYSE: ATS) announced that it will report its financial results for the second quarter ended September 28, 2025, before markets open on Wednesday, November 5, 2025. The company will host a conference call and webcast at 8:30 a.m. Eastern on the same day. The webcast can be accessed via a prov...
2025-10-28AZN6-KAstraZeneca PLC Director Appointmentofficer / director changeLOW
AstraZeneca PLC announced that Euan Ashley, a Non-Executive Director of the Company, has been appointed as a director of DexCom, Inc. effective from 24 October 2025. This announcement is made pursuant to Listing Rule 6.4.9 (2). AstraZeneca is a global, science-led biopharmaceutical company focused on the discovery, dev...
2025-10-28AZN6-KAstraZeneca's Koselugo Approved in the EU for NF1 PN Treatmentoperation relatedHIGH
AstraZeneca PLC announced that Koselugo (selumetinib) has been approved in the European Union for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in adult patients with neurofibromatosis type 1 (NF1). The approval is based on results from the KOMET Phase III trial, which demonstrated a 20% objecti...
2025-10-28FUBO4fuboTV Inc. COO Receives Restricted Stock UnitsAcquired_AMEDIUM
On October 24, 2025, Alberto Horihuela, the Chief Operating Officer of fuboTV Inc., received 350,785 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of fuboTV Inc. common stock. The RSUs will vest in four equal installments on November 23, 2026, November 23, 2027, November 23,...
2025-10-28FUBO4fuboTV Inc. CFO Receives Restricted Stock UnitsAcquired_AMEDIUM
Janedis John, the Chief Financial Officer of fuboTV Inc., received 350,785 restricted stock units (RSUs) on October 24, 2025. Each RSU represents a contingent right to receive one share of fuboTV Inc. common stock. The RSUs will vest in four equal installments on November 24, 2026, November 24, 2027, November 24, 2028,...
2025-10-28FUBO4David Gandler's Restricted Stock Units Grant in fuboTV Inc.Acquired_AMEDIUM
David Gandler, Chief Executive Officer of fuboTV Inc., has been granted 523,560 Restricted Stock Units (RSUs) on October 24, 2025. Each RSU represents a contingent right to receive one share of fuboTV Inc. common stock. The RSUs will vest in four equal installments on November 22, 2026, November 22, 2027, November 22, ...
2025-10-28ZIONP4Executive Vice President Jennifer Anne Smith's Stock TransactionsDisposed_G, Disposed_SMEDIUM
Jennifer Anne Smith, Executive Vice President of Zions Bancorporation, National Association, reported two transactions involving the company's common stock on October 27, 2025. The first transaction was a sale of 2,457.612 shares at a weighted average price of $53.108 per share, resulting in a post-transaction ownershi...
2025-10-28WSBF4Michael L Hansen Sells Shares in Waterstone Financial, Inc.Disposed_SHIGH
Michael L Hansen, a director of Waterstone Financial, Inc., sold a total of 81,413 shares of common stock on October 27, 2025. The shares were sold at a weighted average price of $15.16 per share, with transactions ranging from $15.15 to $15.35. The sales included 1,541 shares held indirectly through a trust and 79,872...
2025-10-28WH4Pauline Richards' Common Stock Transactions in Wyndham Hotels & ResortsAcquired_ALOW
On October 24, 2025, Pauline Richards, a director of Wyndham Hotels & Resorts, Inc., acquired additional shares of common stock. The transactions included the acquisition of 455 shares at $74.76 per share, increasing her total holdings to 17,373 shares, and 337 shares at the same price, increasing her total holdings to...
2025-10-28WH4Ronald L. Nelson's Stock Transactions in Wyndham Hotels & Resorts, Inc.Acquired_AMEDIUM
On October 24, 2025, Ronald L. Nelson, a director of Wyndham Hotels & Resorts, Inc., acquired 515 shares of common stock at a price of $74.76 per share. Following this transaction, Nelson's total holdings in the company increased to 17,363 shares. The filing also details Nelson's other holdings, including 3,511 restric...
2025-10-28WH4Stephen P. Holmes' Stock Transactions in Wyndham Hotels & ResortsAcquired_ALOW
Stephen P. Holmes, a director of Wyndham Hotels & Resorts, Inc., reported a transaction involving the acquisition of 682 shares of common stock on October 24, 2025, at a price of $74.76 per share. Following this transaction, Holmes owns a total of 21,325 shares directly. Additionally, Holmes holds 3,511 restricted stoc...
2025-10-28WH4Director Mukul Deoras Acquires Additional Shares in Wyndham Hotels & ResortsAcquired_AMEDIUM
On October 24, 2025, Mukul Deoras, a director of Wyndham Hotels & Resorts, Inc., acquired 540 shares of common stock at a price of $74.76 per share. Following this transaction, Deoras directly owns 22,075 shares of common stock. The acquisition was part of deferred stock units issued for quarterly retainer fees and div...
2025-10-28WH4James E. Buckman's Stock Transactions in Wyndham Hotels & Resorts, Inc.Acquired_AMEDIUM
On October 24, 2025, James E. Buckman, a director of Wyndham Hotels & Resorts, Inc., acquired 1,026 shares of common stock at a price of $74.76 per share. Following this transaction, Buckman directly owned 91,498 shares of common stock. Additionally, Buckman holds 3,511 restricted stock units and 9,307 shares of common...
2025-10-28WH4Bruce Churchill's Stock Transaction in Wyndham Hotels & ResortsAcquired_ALOW
Bruce Churchill, a director of Wyndham Hotels & Resorts, Inc., acquired 597 shares of common stock on October 24, 2025, at a price of $74.76 per share. This transaction increased his total holdings to 27,215 shares. The shares were acquired as deferred stock units, which entitle Churchill to receive one share of common...
2025-10-28WH4Myra J. Biblowit's Common Stock Transactions in Wyndham Hotels & Resorts, Inc.Acquired_AMEDIUM
On October 24, 2025, Myra J. Biblowit, a director of Wyndham Hotels & Resorts, Inc., acquired additional shares of common stock. The transactions included 434 shares at $74.76 per share, increasing her holdings to 13,273 shares, and 499 shares at the same price, increasing her holdings to 91,477 shares. These acquisiti...
2025-10-28WKC4Andrea B Smith's Restricted Stock Unit Grant in World Kinect CorpAcquired_ALOW
Andrea B Smith, a director of World Kinect Corp, received a grant of 4,259 restricted stock units (RSUs) on October 24, 2025. These RSUs were issued as part of a restricted stock unit grant and will vest on the earlier of the day prior to the next annual meeting of shareholders or the one-year anniversary of the grant ...
2025-10-28WDFC4Jeffrey G. Lindeman's Stock Transactions in WD-40 Co.Disposed_FLOW
Jeffrey G. Lindeman, VP, Chief People, Culture & Capital at WD-40 Co., reported two transactions involving the company's common stock on October 27, 2025. In the first transaction, Lindeman disposed of 260 shares at $0 per share, leaving him with 5,194 shares. In the second transaction, he disposed of 294 shares at $0 ...
2025-10-28WDFC4Phenix Q. Kiamilev's Stock Transactions in WD-40 CoDisposed_FMEDIUM
Phenix Q. Kiamilev, VP, GC & Chief Compliance Officer of WD-40 Co, reported two transactions involving the disposal of shares of Common Stock on October 27, 2025. The first transaction involved the disposal of 267 shares, reducing her holdings to 4,542 shares. The second transaction involved the disposal of 294 shares,...
2025-10-28WDFC4Sara K. Hyzer's Stock Transactions in WD-40 Co.Disposed_FMEDIUM
Sara K. Hyzer, VP, Finance & CFO of WD-40 Co., reported two transactions involving the company's common stock on October 27, 2025. The first transaction involved the disposal of 533 shares at $0 per share, reducing her holdings to 6,190 shares. The second transaction involved the disposal of 455 shares at $0 per share,...
2025-10-28WDFC4Steven A. Brass's Stock Transactions in WD-40 CompanyDisposed_FMEDIUM
Steven A. Brass, President and CEO of WD-40 Company, reported two transactions involving the company's common stock on October 27, 2025. The first transaction involved the disposal of 2,380 shares, reducing his holdings to 35,371 shares. The second transaction involved the disposal of 1,972 shares, further reducing his...
2025-10-28VOYA4Tony D Oh's Stock Transactions in Voya Financial, Inc.Disposed_M, Acquired_M, Disposed_FMEDIUM
Tony D Oh, Senior Vice President, Chief Accounting Officer and Controller of Voya Financial, Inc., reported several stock transactions on October 24, 2025. Oh acquired 1,018 shares of common stock at $73.54 per share and disposed of 301 shares at the same price, resulting in a post-transaction ownership of 717 shares. ...
2025-10-28VANI4Gregg Williams Acquires Additional Shares in Vivani MedicalAcquired_PMEDIUM
On October 27, 2025, Gregg Williams, a director and ten percent owner of Vivani Medical, Inc., acquired 3,703,703 shares of the company's common stock in a private sale transaction at a price of $1.62 per share. This transaction increased his total holdings to 21,350,815 shares. The purchase price was based on the last...